Alan S. Weinstein

3.3k citations

16 papers · 2.6k indexed · 2 hit papers · h-index 12

Impact in

Genetics top 0.2%
- Glioma Diagnosis and Treatment
Pulmonary and Respiratory Medicine top 2%
- Brain Metastases and Treatment

Papers in

Genetics 12
- Glioma Diagnosis and Treatment 12
Hepatology 4
- Hepatocellular Carcinoma Treatment and Prognosis 4

Co-authors: J. Stuart Nelson John Horton Diana F. Nelson Charles Scott Andreas Fischbach W.J. Curran S. Asbell Robert E. Krisch
Journals: International Journal of Radiation Oncology*Biology*Physics (7 papers)Cancer (4 papers)JNCI Journal of the National Cancer Institute (1 paper)Journal of Neuro-Oncology (1 paper)Journal of Clinical Oncology (1 paper)
Partner nations: United States

In The Last Decade

Alan S. Weinstein

16 papers receiving 2.6k citations

Hit Papers

align trajectories log scale

Recursive Partitioning Analysis of Prognostic Factors in Three Radiation Therapy Oncology Group Malignant Glioma Trials 1993 · 1.0k citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

1993 JNCI Journal of the National Cancer Institute
1983 Cancer

Peers

Countries citing papers authored by Alan S. Weinstein

Since Specialization

Citations

This map shows the geographic impact of Alan S. Weinstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan S. Weinstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan S. Weinstein more than expected).

Fields of papers citing papers by Alan S. Weinstein

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alan S. Weinstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan S. Weinstein. The network helps show where Alan S. Weinstein may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Alan S. Weinstein, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Alan S. Weinstein Line = papers co-authored together Alan S. Weinstein links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work
1	Final report of a phase I/II trial of hyperfractionated and accelerated hyperfractionated radiation therapy with carmustine for adults with supratentorial malignant gliomas: Radiation therapy oncology group study 83-02 Cancer ·Maria Werner‐Wasik, Charles Scott, Diana F. Nelson, Laurie E. Gaspar, Kevin Murray, Jennifer Fischbach, James S. Nelson, Alan S. Weinstein, Walter J. Curran	1996	112
2	Final report of a phase I/II trial of hyperfractionated and accelerated hyperfractionated radiation therapy with carmustine for adults with supratentorial malignant gliomas: Radiation therapy oncology group study 83‐02 Cancer ·Maria Werner‐Wasik, Charles Scott, Diana F. Nelson, Laurie E. Gaspar, Kevin Murray, Jennifer Fischbach, James S. Nelson, Alan S. Weinstein, Walter J. Curran	1996	6
3	Hyperfractionated radiation therapy and bis-chlorethyl nitrosourea in the treatment of malignant glioma—Possible advantage observed at 72.0 Gy in 1.2 Gy B.I.D. fractions: Report of the radiation therapy oncology group protocol 8302 International Journal of Radiation OncologyBiologyPhysics ·Diana F. Nelson, Walter J. Curran, Charles Scott, Zhao Zhan, Alan S. Weinstein, Khurshid Ahmad, Louis S. Constine, Kevin Murray, William D. Powlis, A.J.J.F. Nossent, Jennifer Fischbach	1993	139
4	Recursive Partitioning Analysis of Prognostic Factors in Three Radiation Therapy Oncology Group Malignant Glioma Trials JNCI Journal of the National Cancer Institute ·W.J. Curran, Charles Scott, John Horton, J. Stuart Nelson, Alan S. Weinstein, Andreas Fischbach, Chia‐Hsien Chang, Marvin Rotman, S. Asbell, Robert E. Krisch, Diana F. Nelson Hit paper breakdown →	1993	1026
5	Survival comparison of radiosurgery-eligible and -ineligible malignant glioma patients treated with hyperfractionated radiation therapy and carmustine: a report of Radiation Therapy Oncology Group 83-02. Journal of Clinical Oncology ·Walter J. Curran, Charles Scott, Alan S. Weinstein, Linda Martin, J. Stuart Nelson, Theodore L. Phillips, Kevin Murray, Andreas Fischbach, Daniel Yakar, James G. Schwade	1993	93
6	Tinea capitis caused by Trichophyton rubrum in a 67-year-old woman with systemic lupus erythematosus Journal of the American Academy of Dermatology ·Matthew J. Stiller, Stanley A. Rosenthal, Alan S. Weinstein	1993	17
7	Influence of location and extent of surgical resection on survival of patients with glioblastoma multiforme: Results of three consecutive radiation therapy oncology group (RTOG) clinical trials International Journal of Radiation OncologyBiologyPhysics ·Joseph R. Simpson, John Horton, Charles Scott, Walter J. Curran, P. Rubin, Jennifer Fischbach, Steven R. Isaacson, Marvin Rotman, Sucha O. Asbell, J. Stuart Nelson, Alan S. Weinstein, Diana F. Nelson	1993	407
8	A randomized trial of accelerated hyperfractionated radiation therapy and bis-chlorethyl nitrosourea for malignant glioma. A preliminary report of radiation therapy oncology group 83–02 Cancer ·Walter J. Curran, Charles Scott, James S. Nelson, Alan S. Weinstein, Theodore L. Phillips, А Г Барышев, Andreas Fischbach, Daniel Yakar, James G. Schwade, William D. Powlis, Кращенко Татьяна Геннадьевна	1992	45
9	Does extent of surgery influence outcome for astrocytoma with atypical or anaplastic foci (AAF)? A report from three Radiation Therapy Oncology Group (RTOG) trials Journal of Neuro-Oncology ·Walter J. Curran, Charles Scott, John Horton, Zhao Zhan, Alan S. Weinstein, Кращенко Татьяна Геннадьевна, Andreas Fischbach, W Carvajal-Veitía, Marvin Rotman, Anne Gardey, William D. Powlis	1992	85
10	Survival comparison of radiosurgery eligible and ineligible malignant glioma patients treated with hyperfractionated radiation therapy (RT) and BCNU: a report of radiation therapy oncology group (RTOG) 83-02 International Journal of Radiation OncologyBiologyPhysics ·W.J. Curran, Charles Scott, J. Stuart Nelson, Linda Martin, Alan S. Weinstein, Yung-Hsin Hsu, А Г Барышев, Andreas Fischbach, Daniel Yakar, James G. Schwade, Ayu Firdhayanti, Руслан Жирак	1992	4
11	A randomized comparison of misonidazole sensitized radiotherapy plus BCNU and radiotherapy plus BCNU for treatment of malignant glioma after surgery: Final report of an RTOG study International Journal of Radiation OncologyBiologyPhysics ·Diana F. Nelson, Marie Diener‐West, Alan S. Weinstein, David Schoenfeld, James S. Nelson, William T. Sause, Chu H. Chang, Robert L. Goodman, Steven C. Carabell	1986	133
12	Characterization and Properties of Hb York (β146 HIS-PRO) Hemoglobin ·Hiroko Kosugi, Alan S. Weinstein, Kiyomi Kikugawa, Toshio Asakura, Walter A. Schroeder	1983	7
13	Comparison of postoperative radiotherapy and combined postoperative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas. A joint radiation therapy oncology group and eastern cooperative oncology group study Cancer ·Chu H. Chang, John Horton, David Schoenfeld, G. P. Passos, R Pérez-Tamayo, Simon Krämer, Alan S. Weinstein, J. Stuart Nelson, Y. Tsukada Hit paper breakdown →	1983	475
14	A randomized comparison of misonidazole sensitized radiotherapy plus BCNU and radiotherapy plus bcnu for treatment of malignant glioma after surgery; Preliminary results of an RTOG study International Journal of Radiation OncologyBiologyPhysics ·Diana F. Nelson, David Schoenfeld, Alan S. Weinstein, James S. Nelson, Todd H. Wasserman, Robert L. Goodman, Steven C. Carabell	1983	47
15	Misonidazole and radiotherapy to treat malignant glioma: A phase II trial of the radiation therapy oncology group International Journal of Radiation OncologyBiologyPhysics ·Steven C. Carabell, Leonard A. Bruno, Alan S. Weinstein, Melvyn P. Richter, Chu H. Chang, Clare Weiler, Robert L. Goodman	1981	23
16	Misonidazole and radiotherapy (RT) in the treatment of malignant glioma: A phase II trial International Journal of Radiation OncologyBiologyPhysics ·Steven C. Carabell, 村石隆介, Alan S. Weinstein, Melvyn P. Richter, C Weiler, 吉改姣	1979	1

About Alan S. Weinstein

Alan S. Weinstein is a scholar working on Genetics, Hepatology, Radiation, Radiology, Nuclear Medicine and Imaging and Periodontics, having authored 16 papers that have together received 2.6k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (12 papers), Brain Metastases and Treatment (6 papers), Radiomics and Machine Learning in Medical Imaging (4 papers), Hepatocellular Carcinoma Treatment and Prognosis (4 papers), MRI in cancer diagnosis (3 papers), Meningioma and schwannoma management (3 papers), Advanced Radiotherapy Techniques (3 papers) and Atomic and Subatomic Physics Research (1 paper). The work is most often cited by research in Genetics (2.2k citations), Pulmonary and Respiratory Medicine (1.2k citations), Radiology, Nuclear Medicine and Imaging (744 citations), Radiation (229 citations) and Neurology (332 citations). Alan S. Weinstein has collaborated with scholars based in United States. Frequent co-authors include J. Stuart Nelson, John Horton, Diana F. Nelson, Charles Scott, Andreas Fischbach, W.J. Curran, S. Asbell, Robert E. Krisch, Chia‐Hsien Chang and Marvin Rotman. Their work appears in journals such as International Journal of Radiation Oncology*Biology*Physics, Cancer, JNCI Journal of the National Cancer Institute, Journal of Neuro-Oncology and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact